Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D03348 (
Lactase
)
283
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We determined along the small intestine of young and adult rabbits the activities of lactase (
LPH
) and sucrase (SI), the levels of their cognate mRNAs, and examined the in vitro biosynthesis of
LPH
and pro-SI.
Lactase
activity is low in the proximal 1/3 of the intestine, whereas the mRNA levels are high. However, the rates of biosynthesis of the
LPH
forms correlated well with the steady-state levels of
LPH
mRNA in all segments, indicating that factor(s) acting post-translationally produce a decline in brush border
LPH
in the proximal small intestine. These factor(s) are not involved in the processing of pro-
LPH
to mature
LPH
, since the relative amounts of the various forms of
LPH
are almost the same along the small intestine. Unexpectedly, we find that also for SI the ratio of activity to mRNA is low in proximal intestine. The biosynthesis of pro-SI correlates with the steady-state levels of its mRNA. Hence, the steady-state levels of
LPH
and SI along the small intestine are regulated both by mRNA levels and by posttranslational factor(s).
...
PMID:The levels of lactase and of sucrase-isomaltase along the rabbit small intestine are regulated both at the mRNA level and post-translationally. 144 47
Milk lactose is hydrolysed to D-galactose and D-glucose in the small intestine of mammals by the lactase-phlorizin hydrolase complex (
LPH
, EC 3.2.1.23-62).
Lactase
activity has broad substrate selectivity and several glycosides are substrates. Recently, using the monodeoxy derivatives of methyl beta-lactoside (1), we have shown the importance of each hydroxyl group in the substrate molecule concerning the interaction with the enzyme. Now we have studied the corresponding O-methyl derivatives, as well as some of the halo derivatives of 1. We have found that the enzyme presents steric restrictions to the recognition of substrates modified in the galactose moiety. In contrast, the binding site for the aglycon part of the substrate is looser. On the other hand, we have previously shown that HO-3' and HO-6 were important for the recognition of the substrate by the enzyme. Now we have found that the corresponding fluorine derivatives are not, or very poorly, recognized. This suggests that the HO-3' and HO-6 participate, as donors, in hydrogen bonds in the interaction with the enzyme.
...
PMID:Substrate specificity of small-intestinal lactase: study of the steric effects and hydrogen bonds involved in enzyme-substrate interaction. 764 81
Lactase
phlorizin hydrolase (
LPH
; EC 3.2.1.62) is a membrane-bound, family 1 beta-glycosidase found on the brush border of the mammalian small intestine.
LPH
, purified from sheep small intestine, was capable of hydrolysing a range of flavonol and isoflavone glycosides. The catalytic efficiency (k(cat)/K(m)) for the hydrolysis of quercetin-4'-glucoside, quercetin-3-glucoside, genistein-7-glucoside and daidzein-7-glucoside was 170, 137, 77 and 14 (mM(-1) s(-1)) respectively. The majority of the activity occurred at the lactase and not phlorizin hydrolase site. The ability of
LPH
to deglycosylate dietary (iso)flavonoid glycosides suggests a possible role for this enzyme in the metabolism of these biologically active compounds.
...
PMID:Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. 1069 80
Lactase
phlorizin hydrolase is a small intestinal-specific brush border protein commonly used as a specific marker of differentiated enterocytes. A number of transcription factors involved in the enterocyte-specific expression of lactase phlorizin hydrolase have been identified. An upstream regulatory region, which we have named the "LPH enhancer", located at position -894 to -798 in the porcine lactase phlorizin hydrolase gene, is necessary for high differentiation-dependent
LPH
expression in intestinal cells. The
LPH
enhancer was studied by mutation analysis, transfection experiments and electrophoretical mobility shift assays. The
LPH
enhancer is active in intestinal cells (Caco-2) and not in non-intestinal cells (HeLa). The
LPH
enhancer is only able to enhance expression when it is located in front of an intestinal-specific promoter such as the lactase phlorizin hydrolase promoter or the sucrase-isomaltase promoter. In front of an SV40-derived promoter the
LPH
enhancer has no stimulatory effect. In addition to the lack of promoter-promiscuity, the
LPH
enhancer is not a classical enhancer in the sense that it is not orientation-independent and it cannot function when located 3' of a reporter gene. The
LPH
enhancer contains at least three cis-elements (at -894 to -880, -880 to -875 and -833 to -814) with functional importance for the
LPH
enhancer activity.
...
PMID:An enhancer activates the pig lactase phlorizin hydrolase promoter in intestinal cells. 1259 46